Psoriasis
📧 Sign up to get email alerts when something new happens for Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: Randomized, Double-blind, Placebo-controlled Study of RSS0393 Ointment in Healthy and Psoriatic Subjects [Phase 1]
A Phase 1 randomized, double-blind, placebo-controlled study of RSS0393 ointment in healthy and psoriatic subjects is active but not recruit…
-
CLINICAL_TRIALS trial_result · 2025-05-01Clinical Trial Update: A Study Comparing the Risk of Serious Infections and Malignancies With Deucravacitinib or Biologics in Japanese Patients With Psoriasis
This clinical trial update describes a study comparing the risk of serious infections and malignancies between deucravacitinib and biologics…
-
CLINICAL_TRIALS trial_result · 2025-04-30Clinical Trial Update: An Exploratory Study to Evaluate a Digital Intervention to Disrupt Scratching in Atopic Dermatitis and Psoriasis [NA]
This clinical trial update reports the completion of a study evaluating a digital intervention designed to disrupt scratching in adults with…
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: A Study of IBI112 in Chinese Patients With Psoriasis Who Were Previously Treated With Biologics [Phase 2]
Phase 2 trial update of IBI112 in Chinese patients with psoriasis who were previously treated with biologics has completed.
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: A Study of Ustekinumab in Pediatric Participants (U-POPS) With Juvenile Psoriatic Arthritis or Psoriasis [Phase 1]
Phase 1 study of ustekinumab in pediatric participants with Juvenile Psoriatic Arthritis or psoriasis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: A Priming Intervention to Increase Patient Willingness to Use Injectables for the Management of Psoriasis [NA]
This completed clinical trial from Wake Forest University Health Sciences explored a priming intervention to increase psoriasis patients' wi…
-
FDA approval · 2025-04-11FDA Approved: TRIAMCINOLONE ACETONIDE — Original Application (Dr. Reddy's Laboratories Inc)
The FDA approved Dr. Reddy's Laboratories' Triamcinolone Acetonide as an original application (generic) for topical use, adding a generic co…
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: TYK2 Inhibition in Paradoxical Psoriasis [Phase 2, Phase 3]
Terminated Phase 2/Phase 3 trial evaluating a TYK2 inhibitor for psoriasis.
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: HIPPOCRATES Prospective Observational Study
HIPPOCRATES is a prospective observational study sponsored by the University of Oxford. It investigates psoriatic arthritis and psoriasis an…
-
CLINICAL_TRIALS research · 2025-04-01Clinical Trial Update: Exploratory Clinical Study on Fasting in Psoriasis and Psoriatic Arthritis (RiseFast) [NA]
An exploratory clinical study called RiseFast is investigating fasting in psoriasis and psoriatic arthritis. The trial is currently recruiti…
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: Safety, Pharmacokinetics, and Efficacy of RA-18C3 in Subjects With Moderate to Severe Psoriasis [Phase 2]
This Phase 2 trial evaluated the safety, pharmacokinetics, and efficacy of RA-18C3 in adults with moderate-to-severe psoriasis. The study ha…
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: ACT-128800 in Patients With Moderate to Severe Chronic Plaque Psoriasis [Phase 2]
A Phase 2 trial of ACT-128800 in patients with moderate to severe chronic plaque psoriasis has completed. The document notes the study statu…
-
CLINICAL_TRIALS trial_result · 2025-03-28Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants [Phase 3]
Phase 3 pediatric trial evaluating subcutaneously administered guselkumab for chronic plaque psoriasis shows active/not recruiting with resu…
-
CLINICAL_TRIALS trial_result · 2025-03-28Clinical Trial Update: Pleiotropic Role of TRPV1 in Psoriasis Inflammation [NA]
This completed clinical trial investigates the role of TRPV1 signaling in psoriasis-related inflammation. The study, conducted by University…
-
CLINICAL_TRIALS research · 2025-03-27Clinical Trial Update: Evaluation of TNF-α, IL-17A, and YKL-40 in GCF and Serum of Psoriasis Patients and Healthy Controls
This clinical trial update reports an observational study assessing TNF-α, IL-17A, and YKL-40 levels in gingival crevicular fluid and serum …
-
CLINICAL_TRIALS trial_result · 2025-03-25Clinical Trial Update: Efficacy and Safety Study of HRO350 in Patients with Mild-to-moderate Psoriasis (the 'HeROPA' Study). [Phase 2]
Phase 2 study evaluating the efficacy and safety of HRO350 in mild-to-moderate psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-25Clinical Trial Update: A Clinical Study of TQH2929 in Healthy Adult Subjects [Phase 1]
A Phase 1 study of TQH2929 in healthy adult subjects has completed, with psoriasis listed as the condition studied.
-
CLINICAL_TRIALS research · 2025-03-25Clinical Trial Update: Effect of Addition of Pyramidal Exercise to Intermittent Fasting on Dryness of Eye in Pre-diabetic Psoriasis Patients [NA]
A clinical trial is evaluating whether adding pyramidal exercise to intermittent fasting affects dryness of the eye in prediabetic patients …
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: Impact of the Mediterranean Diet on Patients with Psoriasis [NA]
This completed clinical trial investigated the effects of the Mediterranean diet on patients with psoriasis, including assessment of associa…
-
CLINICAL_TRIALS trial_result · 2025-03-18Clinical Trial Update: Bioequivalence Test of Hemay005 Tablets [Phase 1]
Completed Phase 1 bioequivalence study of Hemay005 tablets for psoriasis.
-
EMA approval · 2025-03-17EMA Authorised: Skilarence (dimethyl fumarate) — Almirall, S.A.
EMA has authorized Skilarence (dimethyl fumarate) for the treatment of psoriasis, with Almirall, S.A. as the marketing authorization holder.
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: Real World Study on the Efficacy and Safety of Apremilast in Chinese Patients With Moderate to Severe Plaque Psoriasis, a Multi Center, Prospective, Observational Trial（REACT）
A completed real-world, prospective observational study assessing the effectiveness and safety of apremilast in Chinese adults with moderate…
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Efficacy and Safety of Deucravacitinib Versus Placebo in Participants With Moderate-to-severe Scalp Psoriasis [Phase 4]
Phase 4 trial update showing efficacy and safety of deucravacitinib versus placebo in adults with moderate-to-severe scalp psoriasis, with r…
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Interest of LC-OCT for Diagnosing Inflammatory Dermatoses: ODIN (OCT Dermotoses INflammatoires)
ODIN is a completed clinical trial evaluating the use of LC-OCT to diagnose inflammatory dermatoses, assessing its potential diagnostic valu…
-
CLINICAL_TRIALS trial_result · 2025-03-12Clinical Trial Update: A Herbal Compound for Psoriasis [Phase 2]
A Phase 2 clinical trial evaluating a herbal compound for psoriasis is currently active but not recruiting.